01 12ABX advanced biochemical compounds Biochemische Forschungsreagenzien GmbH
02 1Rotem Industries Ltd
01 1MANNOSE TRIFLATE
02 1Mannose Trflate plus, ultra pure
03 1Mannose Triflat, ultra pure
04 1Mannose Triflate Reference standard
05 1Mannose Triflate for Synthera Module
06 7Mannose Triflate, ultra pure
07 1Mannose triflate, ultra pure
01 1Israel
02 12U.S.A
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0004
Start Marketing Date : 2020-02-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (20mg/20mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0001
Start Marketing Date : 2001-10-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (40mg/40mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0005
Start Marketing Date : 2020-02-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25mg/25mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0003
Start Marketing Date : 2016-01-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (500mg/500mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0008
Start Marketing Date : 2020-02-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25mg/25mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0006
Start Marketing Date : 2020-02-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100mg/100mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0009
Start Marketing Date : 2020-02-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25mg/25mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0007
Start Marketing Date : 2020-02-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1000mg/1000mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0010
Start Marketing Date : 2020-02-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1000mg/1000mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 61704-001
Start Marketing Date : 2014-01-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1mg/mg)
Marketing Category : BULK INGREDIENT
A beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate, including repackagers and relabelers. The FDA regulates beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate supplier is an individual or a company that provides beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate active pharmaceutical ingredient (API) or beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate finished formulations upon request. The beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate suppliers may include beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate API manufacturers, exporters, distributors and traders.
click here to find a list of beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate suppliers with NDC on PharmaCompass.
We have 2 companies offering beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
